hPD-L1/hLAG3

品系全名

C57BL/6JSmo-Cd274tm1(hPD-L1)Lag3tm1(hLAG3)Smoc

目录号

NM-HU-00137

品系状态

胚胎冻存

导出PDF

品系描述

通过hPD-L1(NM-HU-00062)与hLAG3(NM-HU-00049)交配获得。
应用领域:免疫治疗,肿瘤研究,药物筛选

验证数据

pd-l1&lag3.png

图1 FACS检测PD-L1/LAG3双人源化小鼠CD3+T细胞中人源PD-L1&LAG3的表达。结果显示:PD-L1/LAG3双人源化纯合子小鼠通过尾静脉注射刀豆蛋白(12mg/kg)刺激18h,取脾脏细胞进行流式验证。 PD-L1/LAG3人源化纯合子小鼠脾脏的CD3+T细胞中人源PD-L1和LAG3都表达活跃,且都无鼠源PD-L1和LAG3表达。


你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看